Navigation Links
Triple negative breast cancer symposium highlights current advances
Date:4/27/2012

The 5th Annual Jean Sindab Triple Negative Breast Cancer Symposium, sponsored by the Winship Cancer Institute at Emory University, provides an intimate learning environment in which the most current advances in triple-negative breast cancers (TNBC) will be explored. Nationally recognized speakers will review research, clinical experiences, and provide updates on current research in TNBC. TNBC affects young women and African American women disproportionately. TNBC has no targeted therapies and chemotherapy is effective only in a minority of cases. This symposium increases awareness of TNBC and focuses on current, ongoing research to improve outcomes for patients with this disease.

Target Audience

This live activity is designed for medical oncologists, radiation oncologists, surgical oncologists, radiologists, pathologists, and other healthcare providers involved with or interested in the diagnosis, treatment, and management of breast cancer.

Educational Objectives

At the conclusion of the conference, the attendees should be able to:

  • Update adjuvant and neo-adjuvant approaches for treating patients with TNBC

  • Discuss different pathologic subtypes of TNBC

  • Update novel therapeutic approaches for metastatic TNBC

  • Discuss local therapeutic approaches for TNBC

  • Discuss molecular subtyping of TNBC

  • Discuss IGF1R signaling in TNBC

  • Discuss the role of DNA repair defects in TNBC

  • Discuss issues, including fatigue, in breast cancer survivors

Core Competencies: Patient Care and Medical Knowledge

Continuing Medical Education:

The Emory University School of Medicine designates this live activity for a maximum of 7 AMA Physicians Recognition Award Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.


'/>"/>
Contact: Trish Campbell
psnicho@emory.edu
404-788-2218
Emory University
Source:Eurekalert

Page: 1

Related medicine news :

1. Breaking the backbone of triple-negative breast cancers
2. Deaths triple among football players, morning temperatures thought to play a role
3. Injuries to Pedestrians Wearing Headphones Tripled Since 2004
4. SABCS: Loss of RB in triple negative breast cancer associated with favorable clinical outcome
5. First genome sequencing clinical trial for triple negative cancer points to new treatments
6. First whole-genome sequencing clinical trials for triple-negative breast cancer presented
7. Deaths From Abuse of Painkillers Triple in a Decade: CDC
8. Cases of Legionnaires Disease Tripled in 10 Years
9. Triple therapy regime puts patients with leukemic form of cutaneous lymphoma in remission
10. Different subtypes of triple-negative breast cancer respond to different therapies
11. Treatment for Abuse of Anti-Anxiety Drugs Tripled Over 10 Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... TX (PRWEB) January 22, 2015 The Incredible ... Bodybuilder Ben Pakulski to increase lean muscle by up to ... has caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an ... that it is a step-by-step, scientific diet formula that allows ...
(Date:1/22/2015)... The federal court overseeing thousands of vaginal ... Southern District of West Virginia has upheld a $2 million ... bellwether trial. In an Order dated January 21st, the Court ... that C.R. Bard had not proven a miscarriage of justice. ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining the ... . , Auto insurance quotes help many drivers find ... necessary to call an agent or visit an agency for ... single website: http://autocarinsurancebest.com/ . , Every business who relies ...
(Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... American College of Sports Medicine flagship journal Medicine ... supplementation with L-Citrulline before exercise may help reduce ... strenuous exercise. 1 , Participants in the ...
(Date:1/22/2015)... Colorado (PRWEB) January 22, 2015 Four years since ... Queen – which coincided with the marriage of Avasa & Matthew ... THE ROAD, which is scheduled for release through White Swan Records ... message that there is a sacred path available to all of ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
... program addresses growing mental health workforce,crisis, SAN ... mental health workforce crisis, California Institute of Integral,Studies ... in,Community Mental Health in fall 2008., The ... with a,concentration in Community Mental Health, as well ...
... WASHINGTON, Jan. 29 - The American Red Cross,recently ... called Change a Life, which includes print, television, ... The Change a Life campaign demonstrates how ... consumer, donor and internal research,informed the campaign, which ...
... Incorporated,(NYSE: AFL ) announced today that it ... million shares of its common stock in the,first ... be funded,with internal capital., (Logo: http://www.newscom.com/cgi-bin/prnh/20041202/CLTH019LOGO ... repurchase activities, the board of,directors today authorized the ...
... Fla., Jan. 29 NovaVision, Inc. today,announced that ... the 17th,annual Florida Venture Capital Conference (January 29 ... Petersburg, Florida. During the conference Navroze,Mehta, president and ... audience of more than 200 venture capitalists, investment ...
... 29, 2008) -- An enzyme released by mast cells in ... tightening of airways that is a hallmark of asthma -- ... illness. , Reporting in the online edition of Proceedings of ... Medical College explains that during an immune response, mast cells ...
... also lower than researchers anticipated , , TUESDAY, Jan. 29 ... real-life effectiveness of two different drug-coated stents, Danish researchers ... a lower rate of problems than had been anticipated. ... who had these flexible tubes implanted to help keep ...
Cached Medicine News:Health News:California Institute of Integral Studies Launches Groundbreaking Community Mental Health Program 2Health News:California Institute of Integral Studies Launches Groundbreaking Community Mental Health Program 3Health News:American Red Cross Launches 2008 National Public Service Advertising Campaign 2Health News:Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1% 2Health News:Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1% 3Health News:Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1% 4Health News:NovaVision to be Featured at 2008 Florida Venture Capital Conference 2Health News:Lungs' mast cells could provide new treatment target for asthma, other respiratory disease 2Health News:Lungs' mast cells could provide new treatment target for asthma, other respiratory disease 3Health News:Study Finds Both Coated Stents Perform the Same 2Health News:Study Finds Both Coated Stents Perform the Same 3
(Date:1/23/2015)... 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... development and sale of patented biopharmaceutical medicine, modernized traditional ... (API) today announced the business and development progress at ... 1. Following the September 2014 JCM application (No. 51268) ...
(Date:1/22/2015)... Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" ... on Omega-3 therapies for cardiovascular disease and overall health is ... accomplishments in 2014 and its outlook for 2015 from the ... Shareholders, We would like to take this opportunity ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... "Infectious Disease Diagnostics Market by Product, Application, Technology, ... to their offering. , The infectious disease ... 7.9% to reach $18,156.2 million by 2019 from $12,422.8 ...
Breaking Medicine Technology:TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 2Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 3
... Boston Scientific Corporation (NYSE: BSX ) ... Foundation of America (AAFA) to support education initiatives designed ...  The Company,s support coincides with Asthma and Allergy Awareness ... more than 20 million Americans suffer from asthma -- ...
... PARIS, May 10, 2011 Groupe Hospitalier Pitie ... largest medical centers has continued its long tradition ... radiation therapy with the acquisition of Leksell Gamma ... Perfexion – Paris,s first and only dedicated radiosurgery ...
Cached Medicine Technology:Boston Scientific Supports Asthma Awareness Month With Donation to Asthma Foundation 2Boston Scientific Supports Asthma Awareness Month With Donation to Asthma Foundation 3Boston Scientific Supports Asthma Awareness Month With Donation to Asthma Foundation 4First-ever Gamma Knife in Paris Offers New Treatment Options for Patients With Cancer and Other Brain Disorders 2First-ever Gamma Knife in Paris Offers New Treatment Options for Patients With Cancer and Other Brain Disorders 3
Substrate Plasma for Factor X Assay by STA© Analyzers. Freeze-dried human plasma from which factor X has been removed by selective immuno-adsorption....
Immuno-turbidimetric Assay of von Willebrand Factor (vWF) Antigen by STA© Analyzers. Microlatex particles coated with rabbit anti-human vWF antibodies....
Enzyme Immunoassay of Factor IX Antigen by ELISA Method, 96 tests....
Enzyme Immunoassay of -Thromboglobulin Antigen by ELISA Method, 96 tests....
Medicine Products: